Clinical Trial Update: Study of Long-term Peg Intron vs. Colchicine in Non-responders. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing long-term PegIntron (pegylated interferon alfa-2b) versus Colchicine in hepatitis C patients with advanced fibrosis or cirrhosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Cirrhosis
• Liver Fibrosis

Drugs mentioned

• COLCHICINE (Colchicine)
• PegIntron (pegylated interferon alfa-2b)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Hepatitis C Virus, Advanced Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2017-07-11